The use of tyrosine kinase inhibitors (TKIs) in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) has not produced the same durable clinical benefits ...

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...

Researchers at ASCO provided a look at DB-1310 and iza-bren in genomically altered NSCLC, amid an overall survival miss for ...

While smoking is the leading cause of lung cancer it is not the only cause In fact many people develop lung cancer despite ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

Late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

In pancreatic cancer, metastasis is often the first sign that a patient even has cancer, and by then, the cancer has spread ...

A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body.

Results from three trials continue to demonstrate the potential of DATROWAY® (datopotamab deruxtecan) in combination with ...

New research has identified the mechanism by which air pollution damages the lungs’ self-cleaning system, leaving us ...